News
CLIMATE CHANGE
Towards climate resilience, building innovative regions
With more than 15 years of involvement in climate change adaptation and mitigation projects, we have found that these projects face more barriers than any other Project
COVID-19
120 million from Horizon Europe will be allocated to support research into vaccines and treatments as well as network and infrastructure development
The European Commission has announced the eleven preselected projects to tackle coronavirus and its variants, with total funding of €120 million.
They involve 312 research teams from 40 countries, including 38 participants from 23 non-EU countries.
The funded projects will support clinical trials for new treatments and vaccines. In addition, they will assist in the development of large-scale COVID-19 cohorts and networks beyond the borders of Europe.
In addition, they will strengthen and expand access to research infrastructures, such as the European COVID-19 Data Platform and relevant European life sciences research infrastructures.
The successful consortia will collaborate with other relevant initiatives and projects at national, regional, and international level to maximise synergies and complementarity and avoid duplication of the research efforts. They will contribute to building the European Health Emergency Preparedness and Response Authority (HERA), which will enable the EU to anticipate and better tackle future pandemics.
This funding comes from Horizon Europe, Europe’s largest research and innovation programme (2021-2027), and is part of the research and innovation actions that the Commission has taken to fight the coronavirus.
In February, Commission President Ursula von der Leyen announced the start of a European bio-defence preparedness plan HERA Incubator aimed at preparing Europe for an increased threat of coronavirus variants.
In April, the Commission announced the new calls for urgent research into coronavirus variants with an initial budget of €123 million mobilised as part of the first emergency funding under Horizon Europe.
Funding for these 11 projects is conditional on a final Commission decision, and the signature of the Horizon Europe Grant Agreements in the coming months, but the research teams can already start their work.
The project “RBD Dimer recombinant protein vaccine against SARSCoV2” (RBDCOV) one of the initially selected projects is led by the Spanish entity Hipra, and from Zabala Innovation we are grateful and proud to be able to participate in such an interesting challenge as the one posed by this new project.
News
CLIMATE CHANGE
With more than 15 years of involvement in climate change adaptation and mitigation projects, we have found that these projects face more barriers than any other Project
Opinion
ENERGY CRISIS
Alessandro Provaggi
Head of Brussels office
Publication
LIFE 2021-2027
Thanks to our Kaila platform, we have prepared this quick guide with tips for your LIFE proposal and a calendar so you don't miss any key dates
We provide advice to activities that encourage innovation, aimed at promoting the development of new innovative markets from the demand side, through public procurement.
To maximise the success and impact of a project, we manage the communication and dissemination activities, but we also define a social innovation strategy and tools to measure its impact.
We guide companies through the implementation of adequate innovation strategies, which allows them to tackle any transformation challenge in a coordinated and effective manner, from an integrated perspective.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please enable Strictly Necessary Cookies first so that we can save your preferences!
This website uses the following additional cookies:
(List the cookies that you are using on the website here.)
Please enable Strictly Necessary Cookies first so that we can save your preferences!